Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Clinical trial NCT04278768 · SUSPENDED
Trial details
- NCT number
- NCT04278768
- Sponsor
- Curis, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-06
- Primary completion
- 2026-04-01
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.